טוען...
Design of PD-L1 inhibitors for lung cancer
The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interes...
שמור ב:
| הוצא לאור ב: | Bioinformation |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Biomedical Informatics
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677907/ https://ncbi.nlm.nih.gov/pubmed/31435160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015139 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|